Evaluating Adjuvant Therapy Benefits in Stage II Colon Cancer

In this week’s episode, we discuss the management of stage II colon adenocarcinoma, which is defined by a lack of nodal involvement and invasion through the muscularis layer of the colon. If you have not done so already, be sure to check out episode 099 (overview of colorectal cancer) and episode 100 for stage III colon cancer, as we will building on concepts discussed already.

Content:

- Is there a role for adjuvant chemotherapy in stage II colon cancer patients?

- What is the impact on MSI/MMR testing in stage II colon cancer patients?

- Is there a role for evaluating circulating tumor DNA (ctDNA) in colon cancer patients?

- Is there a role for immunotherapy in the adjuvant setting?

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast